These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9758678)

  • 1. Site-specific drug delivery in the dog using flexible fiberoptic endoscopy.
    Heit MC; Smith DF; Enever RP
    J Pharm Sci; 1998 Oct; 87(10):1209-12. PubMed ID: 9758678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rabbit model for sublingual drug delivery: comparison with human pharmacokinetic studies of propranolol, verapamil and captopril.
    Dali MM; Moench PA; Mathias NR; Stetsko PI; Heran CL; Smith RL
    J Pharm Sci; 2006 Jan; 95(1):37-44. PubMed ID: 16307454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic modeling and simulation of etodolac following single oral administration in dogs.
    Baek IH
    Xenobiotica; 2019 Aug; 49(8):981-986. PubMed ID: 30216103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced oral bioavailability of etodolac by self-emulsifying systems: in-vitro and in-vivo evaluation.
    Barakat NS
    J Pharm Pharmacol; 2010 Feb; 62(2):173-80. PubMed ID: 20487196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of rivastigmine from different regions of the gastrointestinal tract in humans.
    Lee L; Hossain M; Wang Y; Sedek G
    J Clin Pharmacol; 2004 Jun; 44(6):599-604. PubMed ID: 15145967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
    Suedee R; Bodhibukkana C; Tangthong N; Amnuaikit C; Kaewnopparat S; Srichana T
    J Control Release; 2008 Aug; 129(3):170-8. PubMed ID: 18550193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human bioavailability of propranolol from a matrix-in-cylinder system with a HPMC-Gelucire core.
    Mehuys E; Remon JP; Korst A; Van Bortel L; Mols R; Augustijns P; Porter C; Vervaet C
    J Control Release; 2005 Oct; 107(3):523-36. PubMed ID: 16055224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study.
    Tsunashima D; Kawamura A; Murakami M; Sawamoto T; Undre N; Brown M; Groenewoud A; Keirns JJ; Holman J; Connor A; Wylde H; Wilding I; Ogawara K; Sako K; Higaki K; First R
    Clin Ther; 2014 May; 36(5):748-59. PubMed ID: 24680768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption.
    Paulson SK; Vaughn MB; Jessen SM; Lawal Y; Gresk CJ; Yan B; Maziasz TJ; Cook CS; Karim A
    J Pharmacol Exp Ther; 2001 May; 297(2):638-45. PubMed ID: 11303053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endoscopy corner: ileoscopy: I. evaluation of "ileostomy dysfunction".
    Waye JD
    Am J Gastroenterol; 1976 Apr; 65(4):360-1. PubMed ID: 937334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of etodolac in the horse following oral and intravenous administration.
    Davis JL; Papich MG; Morton AJ; Gayle J; Blikslager AT; Campbell NB
    J Vet Pharmacol Ther; 2007 Feb; 30(1):43-8. PubMed ID: 17217400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dosing and sampling time on serum thyroxine, free thyroxine, and thyrotropin concentrations in dogs following multidose etodolac administration.
    Ness TA; Torres SM; Kramek EA; Blauvelt MM
    Vet Ther; 2003; 4(4):340-9. PubMed ID: 15136976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The pharmacokinetics of propranolol when used with the propercuten transdermal therapeutic system (experimental data)].
    Piotrovskiĭ VK; Belolipetskaia VG; Vasil'ev AE; Shorr VA; Chichenkov ON; Fel'dshteĭn MM; Metelitsa VI
    Eksp Klin Farmakol; 1993; 56(6):53-6. PubMed ID: 8111301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of selected general anesthetics on pharmacokinetic parameters of some antiarrhythmic drugs in rabbits. Part III. Propranolol.
    Orszulak-Michalak D
    Acta Pol Pharm; 1995; 52(4):309-13. PubMed ID: 8960259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.
    Kiriyama A; Honbo A; Iga K
    Int J Pharm; 2008 Feb; 349(1-2):53-60. PubMed ID: 17765415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast dissolving drug-drug eutectics with improved compressibility and synergistic effects.
    Thipparaboina R; Thumuri D; Chavan R; Naidu VGM; Shastri NR
    Eur J Pharm Sci; 2017 Jun; 104():82-89. PubMed ID: 28366649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic evaluation of conventional and controlled release dosage form of propranolol.
    Das SK; Chattaraj SC
    Arzneimittelforschung; 1990 Jul; 40(7):752-4. PubMed ID: 2222550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving sublingual delivery of weak base compounds using pH(max) concept: application to propranolol.
    Wang Y; Zuo Z; Chen X; Tomlinson B; Chow MS
    Eur J Pharm Sci; 2010 Feb; 39(4):272-8. PubMed ID: 20060467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of preoperative etodolac and butorphanol administration in dogs undergoing ovariohysterectomy.
    Inoue T; Ko JC; Mandsager RE; Payton ME; Galloway DS; Lange DN
    J Am Anim Hosp Assoc; 2006; 42(3):178-88. PubMed ID: 16611929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of indomethacin and etodolac on coronary blood flow and other cardiovascular variables in propranolol-treated dogs.
    Beaulieu G
    Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):283-90. PubMed ID: 3161477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.